More Paradigm Biopharmaceuticals Ltd. news Paradigm Biopharmaceuticals Ltd.ASX: PAR iPPS Increases Cartilage Thickness in Phase 2 Trial Oct 18, 2023 at 2:39 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd. As issuedPlain English Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment